Tuesday 29 September 2015 7:23 am Roche breast cancer drug wins approval for use in UK By: Sarah Spickernell Share Facebook Share on Facebook X Share on Twitter LinkedIn Share on LinkedIn WhatsApp Share on WhatsApp Email Share on Email Add as a preferred source on Google NULL News Updates Stay ahead with our three daily briefings delivering all the key market moves, top business and political stories, and incisive analysis straight to your inbox.
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe Business Wire
Jeito Capital leads oversubscribed $75 million Series C in Adcendo ApS to Advance its First- and Best-in-class Clinical ADC1 Pipeline in Oncology Business Wire
Chemify Founder Publishes Three Papers Validating Chemputation To Reimagine New Chemical Discovery and Development Business Wire